Apyx Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Apyx Medical Corp (APYX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.09 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-03-10
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2017-03-31 was $2.34.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $1.09, a 37.36% decline from fiscal 2024.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $1.74, a 10.77% decline from fiscal 2023.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $1.95, a 70.94% decline from fiscal 2022.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $6.71, a 16.49% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|
| 2025-12-31 | $1.09 10-K · filed 2026-03-10 | |
| 2024-12-31 | $1.74 10-K · filed 2026-03-10 | |
| 2023-12-31 | $1.95 10-K · filed 2025-03-13 | |
| 2022-12-31 | $6.71 10-K · filed 2024-03-21 | |
| 2021-12-31 | $5.76 10-K · filed 2023-03-16 | |
| 2020-12-31 | $4.78 10-K · filed 2022-03-17 | |
| 2019-12-31 | $4.57 10-K · filed 2021-03-31 | |
| 2018-12-31 | $2.40 10-K · filed 2020-03-31 | |
| 2017-12-31 | $1.82 10-K · filed 2020-03-31 | |
| 2017-03-31 | $2.34 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $0.89 10-K · filed 2017-03-10 | |
| 2015-12-31 | $2.21 10-K · filed 2016-03-18 | |
| 2014-12-31 | $1.87 10-K · filed 2015-02-27 | |
| 2013-12-31 | $0.75 10-K/A · filed 2014-05-08 | |
| 2012-12-31 | $1.03 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |